
UC Davis Receives $3.2 Million Award to Study Age-Related Macular Degeneration
Glenn Yiu, an associate professor in the Department of Ophthalmology…

UC Davis Licenses Novel COVID-19 Lung Treatment Using Inhaled Statins to InVixa, Inc
The University of California, Davis and InVixa Inc., a biopharmaceutical…

Update on COVID-19 Research Operations on Campus
Campus leadership recently announced plans for a return to primarily…

Innovative serotonin sensor to improve neurological drug development
(SACRAMENTO) — A research team led by UC Davis scientists used…

Zika Virus Affects Eye Development Before But Not After Birth
By Lisa Howard
While the SARS-CoV-2 virus has dominated the…

New Project Documents How California’s K-12 Schools are Tackling the Pandemic
By Lisa Howard
Over the past 10 months, K-12 school districts…

‘Click Chemistry’ Cancer Treatment Developed by UC Davis Startup Now in Clinical Trials
By Lisa Howard
Shasqi, a startup enabled with technology developed…
https://research.ucdavis.edu/wp-content/uploads/Holiday-Card-Graphic.jpg
400
700
Aj Cheline
https://research.ucdavis.edu/wp-content/uploads/Office-of-Research-logo-235.png
Aj Cheline2020-12-11 11:04:262023-12-27 12:17:21Holiday Greetings from the Office of Research
https://research.ucdavis.edu/wp-content/uploads/Annual_Report_Research.jpg
400
700
Aj Cheline
https://research.ucdavis.edu/wp-content/uploads/Office-of-Research-logo-235.png
Aj Cheline2020-12-08 09:44:322023-12-27 12:17:21Research in Action: The 2019 – 2020 Office of Research Annual Report
Campus Curtailment Impact on Research Support Operations
Updated December 7, 2020
UC Davis has announced a Davis campus…

